Estrella Immunopharma Inc... (ESLA)
NASDAQ: ESLA
· Real-Time Price · USD
0.89
0.03 (3.44%)
At close: Aug 15, 2025, 9:52 AM
3.44% (1D)
| Bid | 0.88 |
| Market Cap | 33.17M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.82M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -3.73 |
| Forward PE | -1.79 |
| Analyst | Buy |
| Ask | 0.9 |
| Volume | 11,050 |
| Avg. Volume (20D) | 177,656 |
| Open | 0.95 |
| Previous Close | 0.86 |
| Day's Range | 0.88 - 0.95 |
| 52-Week Range | 0.63 - 1.78 |
| Beta | 0.34 |
About ESLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ESLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-14%
ESLA stock has given up its prior gain. Estrella I...
Unlock content with
Pro Subscription
2 months ago
-14%
Estrella Immunopharma shares are trading higher. The company anounced an approximate $3.35 million private placement equity financing of 2,333,334 shares of its stock at $1.50 per share.
